- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
IPCA Laboratories Limited — Board Meeting, 26-06-2026: Outcome of Board Meeting
26-06-2026 | 01:12 pm
26-06-2026 | 01:12 pm
Ipca Labs' board approved the merger with Krebs Biochemicals & Industries. This strategic move aims for operational synergies & secures key API supply. Shareholders of Krebs will get 7 Ipca shares (₹1/-) for every 200 Krebs shares (₹10/-).
No comments yet. Be the first to comment!